Skip to main content

Abstract

Objective

The authors sought to identify and evaluate longitudinal mood trajectories and associated baseline predictors in youths with bipolar disorder.

Method

A total of 367 outpatient youths (mean age, 12.6 years) with bipolar disorder with at least 4 years of follow-up were included. After intake, participants were interviewed on average 10 times (SD=3.2) over a mean of 93 months (SD=8.3). Youths and parents were interviewed for psychopathology, functioning, treatment, and familial psychopathology and functioning.

Results

Latent class growth analysis showed four different longitudinal mood trajectories: “predominantly euthymic” (24.0%), “moderately euthymic” (34.6%), “ill with improving course” (19.1%), and “predominantly ill” (22.3%). Within each class, youths were euthymic on average 84.4%, 47.3%, 42.8%, and 11.5% of the follow-up time, respectively. Multivariate analyses showed that better course was associated with higher age at onset of mood symptoms, less lifetime family history of bipolar disorder and substance abuse, and less history at baseline of severe depression, manic symptoms, suicidality, subsyndromal mood episodes, and sexual abuse. Most of these factors were more noticeable in the “predominantly euthymic” class. The effects of age at onset were attenuated in youths with lower socioeconomic status, and the effects of depression severity were absent in those with the highest socioeconomic status.

Conclusions

A substantial proportion of youths with bipolar disorder, especially those with adolescent onset and the above-noted factors, appear to be euthymic over extended periods. Nonetheless, continued syndromal and subsyndromal mood symptoms in all four classes underscore the need to optimize treatment.
Longitudinal studies in adults have shown that bipolar disorder is a lifelong illness manifested by recurrent mood episodes, but the length of asymptomatic periods is highly variable, and some adults with bipolar disorder may have extended periods without recurrences (14). In fact, Kraepelin, at a time when pharmacological treatments for bipolar disorder were not available, reported cases in which remission lasted for several decades (4). Contemporary longitudinal studies of adults and youths with bipolar disorder have reported periods of euthymia lasting up to 60% of the follow-up time and rates of complete recovery between 15% and 30% (19). An analysis of two large epidemiological studies in adults with bipolar disorder (10), one of which had a single 3-year follow-up, found a lower prevalence of episodes of mania or hypomania in patients whose onset of mood symptoms was during late adolescence or early adulthood, particularly in those diagnosed with a less restrictive bipolar disorder category. These findings were not accounted for by several confounding factors, leading the authors to suggest that there may be a developmentally limited subtype of bipolar disorder.
These studies have helped to advance our understanding of the longitudinal course of bipolar disorder. However, most of the evidence that supports bipolar disorder as a chronic illness has been derived from adults who already had a prolonged duration of illness, potentially biasing the results (13, 8, 9). Despite these and other potential methodological limitations (e.g., reporting only syndromal and not subsyndromal recurrences, using small samples, and not evaluating the effects of potential confounders), the existing literature and numerous anecdotal cases give us reason to question the notion that every person with bipolar disorder has a lifelong illness with multiple recurrences (8, 10). This is especially relevant for younger patients, since a diagnosis of bipolar disorder early in life may mean unnecessarily extended exposure to interventions with undesirable potential side effects, time investment, and cost.
Therefore, it is important to evaluate youths with bipolar disorder and follow them prospectively to shed light on the factors that identify patients who have persistent euthymia. Such factors might then be fostered to promote persistent mood stability. In the present study, we sought to identify and evaluate the longitudinal mood trajectories of youths with bipolar disorder, with an emphasis on those who showed persistent euthymia during the follow-up period, and the effects of demographic and clinical variables ascertained at baseline and lifetime family psychiatric history ascertained over the course of the study.

Method

The methods for the Course and Outcome of Bipolar Youth (COBY) study have been described previously (5). Briefly, the study enrolled 413 youths 7–17 years of age with DSM-IV bipolar I or II disorder or with bipolar disorder not otherwise specified as defined operationally by COBY (11). Participants were mainly recruited from outpatient clinics (67.6%) at four university centers. The study excluded patients with schizophrenia, mental retardation, autism, and mood disorders secondary to medical conditions or substance use.
At baseline, youths and parents or primary caretakers were interviewed for psychiatric disorders and treatment with the Schedule for Affective Disorders and Schizophrenia for School-Age Children–Present and Lifetime Version (K-SADS-PL) (12). Severity of mood symptoms was ascertained with the K-SADS Mania Rating Scale (13) and Depression Rating Scale. Week-by-week longitudinal change in psychiatric symptoms was assessed using the Longitudinal Interval Follow-Up Evaluation and the Psychiatric Status Rating Scales (14). The Psychiatric Status Rating Scales use numeric values linked to DSM-IV criteria; for mood disorders, scores ≤2 indicate euthymia, scores of 3–4 subsyndromal symptoms, and scores ≥5 syndromal symptoms. The consensus scores obtained after interviewing parents and their children were used for analyses.
Puberty was assessed with the Petersen Pubertal Development Scale (15). Socioeconomic status was ascertained using the Hollingshead Scale (16). Current and most severe past global functioning was assessed using the Children’s Global Assessment Scale (17).
Parents or primary caretakers were evaluated using the Structured Clinical Interview for DSM-IV (18) and the Global Assessment of Functioning Scale (19). First- and second-degree family psychiatric history was assessed using the Family History Screen (20). Family psychiatric history and parental psychiatric treatment analyzed here represent the summary of data collected during the full length of the study. Family functioning was evaluated using the child and parent versions of the Conflict Behavior Questionnaire (21) and the Family Adaptability and Cohesion Evaluation Scale–II (22).
Assessments were conducted by research staff trained to reliability on the interviews. Child psychiatrists or psychologists confirmed all diagnoses. The kappa values for psychiatric disorders on the K-SADS were ≥0.8. The intraclass correlation coefficients for the K-SADS Mania Rating Scale, the K-SADS Depression Rating Scale, and syndromal/subsyndromal mood disorders ascertained through the Psychiatric Status Rating Scales were ≥0.75.
Each university’s institutional review board approved the study, and consent or assent was obtained from participating youths and their parents.

Statistical Analysis

First, weekly Psychiatric Status Rating Scale scores were aggregated over 6-month intervals, and the percentage of weeks when participants were euthymic (Psychiatric Status Rating Scale scores ≤2) was calculated for each interval. Second, using latent class growth analysis (23), youths were clustered into various classes based on their illness trajectories of percentage of time euthymic during each of the 6-month intervals over the follow-up period. Using the SAS Trajectory procedure (TRAJ) (24), the number of classes was determined by selecting the model with a minimum value of Bayesian information criterion, a minimum of 20 subjects per class, and clinical interpretability of the classes obtained. (For further information regarding the analysis of the latent class analyses, see Table S1 and Figures S1–S8 in the data supplement that accompanies the online edition of this article. For clinical validation of the latent class analyses, see Figures S9 and S10.) Third, univariate analyses using analyses of variance and chi-square tests were performed to compare the demographic, clinical, and family variables between latent class growth analysis classes. All pairwise analyses were corrected for multiple comparisons using the Bonferroni correction. Fourth, multiple regression analyses incorporating variables with p values <0.10 in the univariate comparisons were conducted using a generalized linear model. Odds ratios and confidence intervals were compared between latent class growth analysis classes for variables that remained significant after the multiple regression. All p values are based on two-tailed tests with alpha set at 0.05.

Results

The latent class growth analysis results are based on the prospective evaluation of 367 youths with bipolar disorder (bipolar I disorder, N=218; bipolar II disorder, N=26; bipolar disorder not otherwise specified, N=123) who had at least 4 years of follow-up assessments and up to 96 months of follow-up (Table 1). After intake, participants were interviewed a mean of 10.0 times (SD=3.2), on average every 8.7 months (SD=5.2). The mean duration of follow-up was 93 months (SD=8.3), and 80% of participants (N=292) completed all 96 months of follow-up. The mean age at baseline was 12.6 years (SD=3.3); 46.6% of participants were female, 82.6% were Caucasian, 42.0% lived with both biological parents, and the average socioeconomic status score was 3.4 (SD=1.2), or Hollingshead class III, which corresponds to middle class.
TABLE 1. Duration of Follow-Up and Psychiatric Status Rating Scale Scores for Youths With Bipolar Disorder During Longitudinal Follow-Upa
MeasureClass 1: Predominantly Euthymic (N=88)Class 2: Moderately Euthymic (N=127)Class 3: Ill With Improving Course (N=70)Class 4: Predominantly Ill (N=82)p
 MeanSDMeanSDMeanSDMeanSD 
Duration of follow-up (months)92.47.893.67.093.09.993.09.20.8
Time between interviews (months)9.125.08.51,43.78.445.49.12,36.80.002
Number of follow-up interviews9.72.510.32.810.63.59.53.80.1
Percent of time euthymic84.42,3,49.447.31,415.242.81,412.311.51,2,37.8<0.001
Maximum consecutive months euthymic44.22,3,421.112.61,3,48.220.11,2,410.95.51,2,34.4<0.001
Percent of time in any syndromal mood2.92,3,43.314.31,413.315.41,413.626.91,2,321.9<0.001
 Depression1.72,3,42.910.61,412.010.71,411.321.51,2,319.9<0.001
 Mania or hypomania1.32,3,42.34.41,45.95.818.78.21,211.9<0.001
 Mixed state0.1440.70.6841.91.1442.82.761,2,36.2<0.001
Psychiatric Status Rating Scale         
 Mean scores         
  Depression1.42,3,40.32.21,40.62.41,40.53.21,2,30.7<0.001
  Mania1.040.11.140.11.10.21.21,20.3<0.001
  Hypomania1.32,3,40.31.81,40.52.01,40.52.61,2,30.6<0.001
 Mean highest scores         
  Depression4.12,3,41.35.010.75.010.95.210.7<0.001
  Mania2.92.22.82.12.82.13.42.10.17
  Hypomania3.92,3,41.14.610.84.410.84.610.7<0.001
 Variability in scores during follow-upb23.82,311.132.81,3,46.940.51,2,45.621.62,311.6<0.001
 N%N%N%N% 
New syndromal episodes during follow-up         
 Any mood4551.12,3,411792.115984.317591.51<0.001
 Mania, hypomania, or mixed state2629.62,3,48869.314361.415364.61<0.001
 Depressed2933.02,3,410582.715375.717085.41<0.001
a
Superscripts denote significant between-class differences, with p values ≤0.05 after Bonferroni correction.
b
Measured by comparing the mean standard deviations over follow-up.

Latent Class Growth Analysis

Latent class growth analysis identified four mood trajectory classes based on Psychiatric Status Rating Scale scores ≤2 (Figure 1): class 1, “predominantly euthymic” (N=88; 24.0%); class 2, “moderately euthymic” (N=127; 34.6%); class 3, “ill with improving course” (N=70; 19.1%); and class 4, “predominantly ill” (N=82; 22.3%). Within these classes, youths were euthymic on average 84.4%, 47.3%, 42.8%, and 11.5% of the follow-up time, respectively. As illustrated in Figure 1, youths in classes 1, 3, and 4 showed significant changes in their trajectories toward improvement at 6, 36, and 84 months, respectively (all p values <0.001).
FIGURE 1. Latent Class Growth Analysis Based on Percentage of Time Euthymic for Youths With Bipolar Disorder Who Had at Least 4 Years of Follow-Up
As shown in Table 1, there were no between-class differences in the duration of follow-up or number of interviews. With the exception of the mean highest Psychiatric Status Rating Scale score for mania, youths in class 1 had a significantly higher percentage of time and maximum number of consecutive weeks in euthymia, and regardless of polarity, had a lower percentage of time with syndromal mood symptoms (Psychiatric Status Rating Scale scores ≥5), lower mean Psychiatric Status Rating Scale scores, and lower mean highest Psychiatric Status Rating Scale scores when compared with youths in class 4 (p values <0.001). With the exception of youths in class 3 having significantly more maximum consecutive weeks in euthymia than those in class 2, there were no other differences between these two classes. Also, in general, the Psychiatric Status Rating Scale scores of youths in these two classes were between those of youths in classes 1 and 4.
The variability of the Psychiatric Status Rating Scale scores over the follow-up period was evaluated by comparing the mean standard deviations of Psychiatric Status Rating Scale scores among the four classes. Scores in class 3 had significantly more variability than those in class 2, and scores in both of these classes showed more variability than those in classes 1 and 4 (p values <0.001). There were no variability differences between classes 1 and 4.

Demographic Variables

As shown in Table 2, youths in class 1 were significantly older than those in classes 3 and 4, had higher socioeconomic status than those in the other three classes, and were more frequently living with both biological parents than those in class 4 (p values <0.03).
TABLE 2. Baseline Demographic and Clinical Characteristics of Youths With Bipolar Disordera
CharacteristicClass 1: Predominantly Euthymic (N=88)Class 2: Moderately Euthymic (N=127)Class 3: Ill With Improving Course (N=70)Class 4: Predominantly Ill (N=82)p
Demographic variables         
 MeanSDMeanSDMeanSDMeanSD 
Age (years)13.63,43.412.83.112.313.311.713.30.001
Hollingshead Index of Social Status3.92,3,41.23.411.13.3 11.13.011.3<0.001
 N%N%N%N% 
Tanner stage of sexual development        0.08
 I–III2640.65855.83159.64261.8 
 IV2132.82927.91732.71420.6 
 V1726.61716.447.71217.7 
Female4348.95543.33347.14048.80.8
White7383.010784.35882.96579.30.8
Living with both biological parents4652.345543.32738.62631.710.05
Clinical variables         
 MeanSDMeanSDMeanSDMeanSD 
Age at onset of mood symptoms (years)10.42,3,44.38.31,44.07.713.96.91,23.2<0.001
Age at onset of first manic symptoms (years)12.144.010.44.211.44.19.113.80.01
Age at onset of first major depressive episode (years)12.42,3,43.410.313.810.313.79.313.80.003
Duration of mood symptoms (years)3.182,3,42.84.4513.04.9513.14.9112.8<0.001
Mania Rating Scale score20.3313.921.7311.826.71,211.224.611.00.004
Depression Rating Scale score10.32,3,410.815.6110.216.218.915.719.5<0.001
Children’s Global Assessment Scale         
 Score54.014.856.011.454.711.754.410.70.7
 Most severe past score39.19.036.911.638.910.136.511.20.3
 N%N%N%N% 
Bipolar disorder type        0.3
 Type I5663.67659.83955.74757.3 
 Type II89.1107.911.478.5 
 Not otherwise specified2427.34132.33042.92834.2 
Polarity         
 Depressed1213.62418.9710.078.50.1
 Manic or hypomanic3640.92,33023.611318.612530.50.008
 Mixed state1517.12116.51318.61012.20.7
 Subsyndromal mood symptoms (bipolar disorder not otherwise specified)2528.43,45240.93752.914048.810.009
More than 1 mood episode         
 Syndromal3843.227962.213651.44757.30.04
 Subsyndromal1921.62,35644.113347.113239.00.002
Mixed state2326.13527.62130.01923.20.8
Psychosis1112.53225.21825.72024.40.1
Childhood onset of mood symptoms2528.43,45744.93448.614757.310.002
Self-injurious behavior2022.72,45341.712637.13643.910.01
Suicidal ideation4955.72,3,410280.315477.116579.31<0.001
Suicide attempt1415.924837.811724.32732.90.004
Physical or sexual abuse66.82,43124.411420.02024.410.006
 Physical abuse66.81612.61115.71518.30.1
 Sexual abuse11.12,42116.5168.61214.610.003
Comorbid disorders         
 Attention deficit hyperactivity disorder3742.13,47559.14564.315972.01<0.001
 Conduct disorder or oppositional defiant disorder3843.25442.53550.04959.80.07
 Anxiety disorder1820.12,3,45240.913448.613542.710.001
 Substance use disorder55.7118.745.756.10.8
 Pervasive developmental disorder not otherwise specified or Asperger’s syndrome22.397.168.61012.20.1
a
Superscripts denote significant between-class differences, with p values ≤0.05 after Bonferroni correction.

Clinical Variables

As shown in Table 2, youths in class 1 had a significantly higher age at onset of mood symptoms, higher age at onset of first depressive episode, shorter duration of previous mood symptoms, lower depression severity, and lower incidences of suicidal ideation, and comorbid anxiety disorders at baseline. In addition, youths in class 1 had more prospectively ascertained syndromal mood episodes than youths in the other three classes, as shown in Table 1. At baseline, those in class 1 also were more likely to have had a manic or hypomanic presentation and less likely to have a history of more than one subsyndromal episode than youths in classes 2 and 3; were less likely to have subsyndromal mood symptoms, childhood onset of mood symptoms, and a history of attention deficit hyperactivity disorder (ADHD) than youths in classes 3 and 4; were less likely to have a history of syndromal episodes than youths in class 2; and had lower mania severity than youths in class 3 and higher age at onset of manic episodes than youths in class 4.
Finally, youths in class 1 were less likely to have a baseline history of self-injurious behaviors than those in classes 2 and 4, less likely to have a history of suicide attempt than those in class 2, and less likely to have had physical and sexual abuse than those in classes 2 and 4. Youths in class 2 had a significantly higher age at onset of mood symptoms than those in class 4 and lower mania scores than those in class 3 (p values <0.05). There were no other clinical differences among the four classes, including bipolar disorder subtypes. Youths in all four classes had a history of poor functioning without significant differences among them.

Treatment History

Across all classes, history of exposure to psychiatric services beginning at an early age was common (Table 3). About half of the sample had a history of at least one inpatient admission, and most had been exposed to several medications, particularly mood stabilizers and antipsychotics. Youths in class 1 were less likely to have been treated with stimulants than those in the other three classes, were older at the time of first outpatient and inpatient treatments than those in classes 3 and 4, and were older and had fewer hospitalizations than those in class 4 (p values <0.03).
TABLE 3. History of Psychiatric Treatment and Exposure to Psychotropic Medications in Youths With Bipolar Disordera
MeasureClass 1: Predominantly Euthymic (N=88)Class 2: Moderately Euthymic (N=127)Class 3: Ill With Improving Course (N=70)Class 4: Predominantly Ill (N=82)p
Treatment
 MeanSDMeanSDMeanSDMeanSD 
Age at first outpatient treatment (years)8.63,44.58.03.96.913.16.913.30.006
Total duration of outpatient treatment (weeks)168162.6189.1148.5222.9149.4212.7157.50.1
Age at first hospitalization (years)12.93,43.711.63.710.313.910.013.60.001
Number of hospitalizations0.6941.01.141.4 41.32.21.81,23.10.004
 N%N%N%N% 
Outpatient services7888.6412296.16998.68198.810.009
Psychiatric hospitalization4045.56853.53550.74757.30.5
History of exposure to psychotropic medications (at baseline)
Any psychotropic medication8293.212296.16694.37996.30.7
Antipsychotics4247.77861.44057.15364.60.1
Antidepressants4247.77962.24564.35465.90.06
Stimulants3337.52,3,47458.314260.015567.11<0.001
Lithium or anticonvulsants6573.99373.24868.66275.60.8
Atomoxetine78.0118.71014.31518.30.1
Benzodiazepines55.71511.834.367.30.2
Alpha-2 agonists1314.82822.11521.41923.20.5
a
Superscripts denote significant between-class differences, with p values ≤0.05 after Bonferroni correction.

Family Psychiatric History, Functioning, and Treatment

Data were available for 701 biological parents, 49.8% of whom were biological mothers. For 327 of them (46.6%), the information was obtained by direct interview, and for 374 of them (53.3%), it was obtained indirectly through the family history. The results of the first- and second-degree family history were combined because separate analyses yielded similar results.
As shown in Table 4, youths in class 1 were significantly less likely to have a family history of ADHD and suicide attempt than those in the other three classes. They were less likely to have a family history of bipolar disorder, depression, and anxiety disorders than those in classes 2 and 4, and less likely to have a family history of conduct disorder and substance use disorders than those in class 4. Youths in class 2 were less likely to have familial ADHD, conduct disorder, and substance use disorders than those in class 4. Youths in class 1 were less likely to have mothers with depression than those in classes 2 and 4, and less likely to have mothers with bipolar disorder, anxiety disorders, ADHD, or substance use disorders than those in class 4. Youths in class 1 were less likely to have fathers with substance use disorders than those in classes 3 and 4, and less likely to have fathers with bipolar disorder, anxiety, ADHD, or conduct disorder than those in class 4. Finally, youths in class 2 were less likely to have fathers with conduct disorder and substance use disorders than those in class 4.
TABLE 4. Family (First- and Second-degree), Maternal, and Paternal Lifetime Psychiatric History of Youths With Bipolar Disordera
 Class 1: Predominantly Euthymic (N=88)Class 2: Moderately Euthymic (N=127)Class 3: Ill With Improving Course (N=70)Class 4: Predominantly Ill (N=82) 
VariableN%N%N%N%p
Lifetime family history         
Lifetime bipolar disorder3236.42,48063.013651.45972.01<0.001
Lifetime depression or dysthymia4955.72,49372.214868.66275.610.02
Lifetime anxiety disorder4652.32,49171.714868.66478.110.002
Lifetime non-mood psychosis11.110.800.011.21
ADHD2022.72,3,45442.51,44158.615263.41,2<0.001
Conduct disorder1618.244333.942535.74453.71,2<0.001
Substance use disorders4753.448768.545071.47287.81,2<0.001
Suicide attempt2528.42,3,45644.113144.314150.010.02
Mother’s lifetime history         
Lifetime bipolar disorder1214.342519.71319.72632.110.04
Lifetime depression or dysthymia3547.62,47570.914068.25576.51<0.001
Lifetime anxiety disorder2428.644837.82334.94049.410.05
Lifetime non-mood psychosis00.000.000.000.0
ADHD22.44129.5913.61619.810.004
Conduct disorder00.053.946.156.20.08
Substance use disorders89.542418.91319.72227.210.04
Suicide attempt89.51511.81015.21721.00.2
Father’s lifetime history         
Lifetime bipolar disorder1012.242116.71421.22430.010.03
Lifetime depression or dysthymia1035.43054.01142.41841.30.05
Lifetime anxiety disorder44.941915.11218.22430.01<0.001
Lifetime non-mood psychosis00.000.000.011.30.4
ADHD67.341713.5913.62227.510.003
Conduct disorder44.941411.141116.72126.31,2<0.001
Substance use disorders1822.03,43931.042842.414860.01,2<0.001
Suicide attempt89.8129.534.61215.00.2
a
Superscripts denote significant between-class differences, with p values ≤0.05 after Bonferroni correction. ADHD=attention deficit hyperactivity disorder.

Overall Functioning in Parents or Primary Caretakers

The parents or primary caretakers of youths in class 1 had significantly higher current, most severe past, and highest past Global Assessment of Functioning scores than those of youths in class 4 (see Table S2 in the online data supplement). Also, parents or primary caretakers of youths in class 2 had significantly higher current Global Assessment of Functioning scores than those of youths in class 4 (p values ≤0.03).

Parental Psychiatric Treatment

Mother of youths in class 1 were less likely to have a history of treatment than those of youths in classes 3 and 4 and less likely to have had psychiatric hospitalizations than those of youths in class 4 (see Table S2 in the online data supplement). Mothers of youths in class 2 were less likely to have had hospitalizations than those of youths in class 4, and fathers of youths in class 1 were less likely to have a history of outpatient treatment than those of youths in class 3 (p values <0.04).

Family Functioning and Conflicts

Parents of youths in classes 1 and 2 reported less conflict than parents of those in class 3. There were no other between-class differences in family functioning and conflicts as reported by the parents and youths (see Table S2 in the online data supplement).

Multivariate Analyses

After multivariate analyses, eight variables were associated as follows with better course: higher age at onset of mood symptoms (χ2=25.57, p=0.001), less lifetime family history of bipolar and substance use disorders (χ2=13.02, p=0.005 and χ2=11.73, p=0.008, respectively), and less history at baseline of severe depression (χ2=9.84, p=0.02) or manic or hypomanic symptoms (χ2=10.46, p=0.02), fewer subsyndromal episodes (χ2=10.36, p=0.02), less history of suicide attempt (χ2=8.05, p=0.05), and less history of sexual abuse (χ2=8.16, p=0.04). Higher socioeconomic status was associated with better illness course, but the association fell short of significance (χ2=7.17, p=0.07). There were also significant interactions between age at onset of mood symptoms and severity of depression and socioeconomic status. The effects of age at onset became nonsignificant in youths with lower socioeconomic status (Hollingshead classes I and II). Also, the effects of depression severity diminished and were nonsignificant in youths with higher socioeconomic status (Hollingshead class V). There were no other significant interactions.
For each of these eight variables, odd ratios were compared among the four trajectory classes (Table 5). The variables were associated as follows with a greater likelihood of class 1 membership: higher age at onset of mood symptoms and less severe depression compared with classes 2, 3, and 4; fewer subsyndromal episodes compared with classes 2 and 3; less sexual abuse and lifetime family history of bipolar disorder and suicide attempt compared with classes 2 and 4; less severe manic symptoms compared with class 3; and less family substance abuse compared with class 4. Less severe manic symptoms and higher age at onset and less family substance abuse were associated with a greater likelihood of belonging to class 2 compared with classes 3 and 4, respectively. Finally, less family substance abuse was associated with a greater likelihood of belonging to class 3 compared with class 4 (p values ≤0.03).
TABLE 5. Comparison of Significant Variables From the Multivariate Analyses Among the Four Mood Trajectory Classesa
 Class 1 Versus Class 2Class 1 Versus Class 3Class 1 Versus Class 4Class 2 Versus Class 3Class 2 Versus Class 4Class 3 Versus Class 4
VariableOdds RatioCIpOdds RatioCIpOdds RatioCIpOdds RatioCIpOdds RatioCIpOdds RatioCIp
Child variables                  
Age at onset of mood symptoms1.151.06, 1.25<0.0011.181.08, 1.29<0.0011.281.16, 1.41<0.0011.111.02, 1.210.02
Severity of manic or hypomanic symptoms at baseline0.960.93, 0.990.0050.960.93, 0.990.008
Severity of depression at baseline0.950.92, 0.980.0040.950.92, 0.990.010.950.91, 0.990.009
History of >1 subsyndromal episode0.360.18, 0.720.0040.320.15, 0.690.004
History of suicide attempt0.390.18, 0.840.020.340.14, 0.810.02
Sexual abuse0.060.007, 0.480.0080.060.007, 0.550.01
Family variablesb                  
Lifetime family history of bipolar disorder0.360.19, 0.700.0030.310.15, 0.670.0030.490.24, 0.990.05
Lifetime family history of substance abuse0.220.09, 0.54<0.0010.340.15, 0.750.008
a
Class 1: predominantly euthymic; class 2: moderately euthymic; class 3: ill with improving course; class 4: predominantly ill.
b
There were significant interactions between socioeconomic status and child’s age at onset of mood symptoms and child’s severity of depression. The effects of age at onset decreased in youths with lower socioeconomic status, and the effects of depression severity decreased in those with higher socioeconomic status.

Discussion

To our knowledge, this is the first study to prospectively characterize long-term mood trajectories in youths with bipolar disorder with an emphasis on patients with a predominantly euthymic course. After approximately 8 years of follow-up, four different mood trajectories were identified. At one extreme, 24.0% of the youths were “predominantly euthymic,” being euthymic 84.4% of the follow-up time (class 1). At the other extreme, 22.3% of the sample was “predominantly ill,” being euthymic only 11.5% of the follow-up time (class 4). Between these two classes, 34.6% of the youths were “moderately euthymic,” being euthymic 47.3% of the follow-up time (class 2), and 19.1% were mostly ill during the first months of the follow-up and then steadily improved (“ill with improving course”), being euthymic on average 42.8% of the follow-up time (class 3). Youths in classes 1 and 4 showed significantly more stable scores on the Psychiatric Status Rating Scales than those in classes 2 and 3.
At baseline, rates of bipolar disorder subtypes and history of poor functioning were similar across all four classes, and all classes (particularly class 4) had high rates of comorbid psychopathology, psychosocial and pharmacological treatments, history of physical or sexual abuse, poor individual and family functioning, and familial psychopathology. Of all these variables, six that were related to the youths and two that were related to the family remained significantly associated with better longitudinal course in the multivariate analyses: higher age at onset of mood symptoms, less severe depression, less severe manic or hypomanic symptoms, fewer subsyndromal episodes, fewer suicide attempts, less history of sexual abuse, and less family history of bipolar disorder or substance use disorders.
Youths with higher socioeconomic status had a better course, but this association did not reach significance. The effect of socioeconomic status was more notable in its role of moderating the effects of age at onset of mood symptoms and severity of depression. The effects of age at onset were not significant in youths with lower socioeconomic status, and there were no effects of depression severity in youths with higher socioeconomic status.
Before discussing these findings, it is important to note the limitations of this study. The data collected through the Longitudinal Interval Follow-Up Evaluation are subject to recall bias. The study included few participants with bipolar II disorder (7%). Also, the generalizability of the observations to other populations remains uncertain because most participants were Caucasian, and they were recruited primarily from outpatient settings. Nevertheless, course and morbidity in non-clinically referred adolescents with bipolar disorder have been shown to be similar to those in referred populations (25).
The results of this study present a more optimistic perspective on what has been thought to be a universally chronic illness. Although some 22% of the sample was persistently ill, when we combine class 1 (predominantly euthymic) and class 3 (ill with improving course), by the end of follow-up, 43% of the sample was euthymic most of the time. Nevertheless, it is important to note that despite being predominantly euthymic, over 50% of the youths in class 1 continued to experience new syndromal manic or depressive episodes, indicating that they continued to have active, clinically meaningful bipolar symptoms and the need for maintenance treatment. Our results extend the findings of clinically referred studies that followed bipolar youths (6, 7, 2628) and adults (13, 8, 9). Reports including nonreferred samples of adults (10) and a small study of adolescents (25) with bipolar disorder have also suggested that a subgroup of patients may achieve remission over time. However, we cannot directly compare our results with these studies because they did not indicate the prevalence or duration of persistent periods of euthymia.
Youths in class 4 (predominantly ill) had chronic mood symptoms and had significantly higher rates of ADHD and anxiety disorders at baseline than those in class 1, raising the question of whether these youths had other disorders and not bipolar disorder. However, in the multivariate analyses, the effects of the comorbid disorders disappeared, and youths in class 4 had significantly more family history of mania and earlier onset of mood disorders than those in class 1, significantly more prospectively ascertained syndromal mood episodes than the other three classes, and a prevalence of bipolar subtypes and history of exposure to mood stabilizers similar to the other three classes, suggesting that youths in class 4 indeed had a more severe and treatment-resistant bipolar disorder.
Consistent with other studies, early age at onset of mood symptoms was associated with poor longitudinal course (e.g., 1, 5, 6, 8, 2932). We extended these findings by noting that the effects of age at onset were not accounted for by duration of the illness. Thus, early-onset bipolar disorder may be a more severe type of bipolar disorder, or having a mood disorder early in life may interfere with normal psychosocial development and thus set the stage for a more chronic course (e.g., 1, 5, 6, 8, 2932). However, the effects of age at onset were less relevant in youths with lower socioeconomic status, emphasizing the well-documented association between low socioeconomic status and greater psychopathology and worse longitudinal outcome (e.g., 1, 7, 33, 34).
Several longitudinal studies have also shown that severity of depression, suicide attempt, recurrent subsyndromal mood episodes, and history of sexual abuse are predominant features of bipolar disorder and are associated with poor longitudinal outcome, underscoring the need for successful management and prevention of these factors in bipolar youths (e.g., 1, 5, 7, 8, 29, 3537).
The few studies that have evaluated the effects of family history on the longitudinal course in bipolar adults have also shown that family histories of manic episodes and substance use disorder were associated with poor outcome (36, 3840). There are no reports on the effects of family history on the course of illness in youths with bipolar disorder, but a high-risk study reported that the severity of psychopathology in the offspring of parents with bipolar disorder was related to the number of manic or mixed episodes, but not to depression (41). The presence of parental bipolar disorder and parental substance use disorder may be a marker for more severe bipolar disorder in offspring, or perhaps these factors are associated with less parental monitoring and poorer family functioning and consequently more severe psychopathology in offspring. In fact, in our sample, parents with substance use disorder had significantly more psychopathology, lower socioeconomic status, and poorer family functioning than parents without substance use disorders (data not shown).
In summary, a substantial proportion of youths with bipolar disorder, especially those whose illness started later in adolescence and who at baseline had less severe depression and manic or hypomanic symptoms, had less history of subsyndromal episodes, suicide attempt, and sexual abuse, and had less lifetime family history of bipolar disorder, are more likely to be euthymic over extended periods. However, these youths, and particularly those in the other classes, continued to present syndromal and subsyndromal mood symptoms, indicating the need to optimize treatment or develop new treatments. In addition to identifying classes that may be amenable to neurobiological research, this line of research also underscores the importance of acknowledging that good outcomes are not uncommon in bipolar disorder.

Acknowledgments

The authors thank the families for their participation, and Melissa Cade, the Course and Outcome of Bipolar Youth research staff, and Shelli Avenevoli, Ph.D., from NIMH, for their support.

Supplementary Material

Supplementary Material (990_ds001.pdf)

References

1.
Goodwin FK, Jamison KR: Manic-Depressive Illness. New York, Oxford University Press, 2007
2.
Angst J, Sellaro R: Historical perspectives and natural history of bipolar disorder. Biol Psychiatry 2000; 48:445–457
3.
Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, Leon AC, Rice JA, Keller MB: The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59:530–537
4.
Kraepelin E: Manic-Depressive Insanity and Paranoia. Translated by Barclay RM, edited by Robertson GM. Edinburgh, E & S Livingstone, 1921
5.
Birmaher B, Axelson D, Goldstein B, Strober M, Gill MK, Hunt J, Houck P, Ha W, Iyengar S, Kim E, Yen S, Hower H, Esposito-Smythers C, Goldstein T, Ryan N, Keller M: Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry 2009; 166:795–804
6.
Geller B, Tillman R, Bolhofner K, Zimerman B: Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. Arch Gen Psychiatry 2008; 65:1125–1133
7.
DelBello MP, Hanseman D, Adler CM, Fleck DE, Strakowski SM: Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. Am J Psychiatry 2007; 164:582–590
8.
Goldberg JF, Harrow M: Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up. J Affect Disord 2004; 81:123–131
9.
Tohen M, Waternaux CM, Tsuang MT: Outcome in mania: a 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 1990; 47:1106–1111
10.
Cicero DC, Epler AJ, Sher KJ: Are there developmentally limited forms of bipolar disorder? J Abnorm Psychol 2009; 118:431–447
11.
Axelson DA, Birmaher B, Strober MA, Goldstein BI, Ha W, Gill MK, Goldstein TR, Yen S, Hower H, Hunt JI, Liao F, Iyengar S, Dickstein D, Kim E, Ryan ND, Frankel E, Keller MB: Course of subthreshold bipolar disorder in youth: diagnostic progression from bipolar disorder not otherwise specified. J Am Acad Child Adolesc Psychiatry 2011; 50:1001–1016.e3
12.
Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children–Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36:980–988
13.
Axelson D, Birmaher BJ, Brent D, Wassick S, Hoover C, Bridge J, Ryan N: A preliminary study of the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children mania rating scale for children and adolescents. J Child Adolesc Psychopharmacol 2003; 13:463–470
14.
Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC: The Longitudinal Interval Follow-Up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 1987; 44:540–548
15.
Petersen AC, Crockett L, Richards M, Boxer A: A self-report measure of pubertal status: reliability, validity, and initial norms. J Youth Adolesc 1988; 17:117–133
16.
Hollingshead AB: Four-Factor Index of Social Status. New Haven, Conn, Yale University, Department of Sociology, 1975
17.
Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S: A Children’s Global Assessment Scale (CGAS). Arch Gen Psychiatry 1983; 40:1228–1231
18.
Spitzer RL, Williams JBW, Gibbon M, First MB: Instruction Manual for the Structured Clinical Interview for DSM-III-R (SCID). New York, New York State Psychiatric Institute, Biometrics Research, 1989
19.
Endicott J, Spitzer RL, Fleiss JL, Cohen J: The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33:766–771
20.
Weissman MM, Wickramaratne P, Adams P, Wolk S, Verdeli H, Olfson M: Brief screening for family psychiatric history: the family history screen. Arch Gen Psychiatry 2000; 57:675–682
21.
Robin AL, Foster SL: Negotiating Parent-Adolescent Conflict. New York, Guilford, 1989
22.
Olson DH, Bell RQ, Portner J: FACES II: Family Adaptability and Cohesion Evaluation Scales. Minneapolis, Life Innovations, 1982
23.
Jung T, Wickrama KAS: An introduction to latent class growth analysis and growth mixture modeling. Soc Personal Psychol Compass 2008; 2:302–317
24.
Jones BL, Nagin DS, Roeder K: An SAS procedure based on mixture models for estimating developmental trajectories. Sociol Methods Res 2001; 29:374–393
25.
Lewinsohn PM, Klein DN, Seeley JR: Bipolar disorder during adolescence and young adulthood in a community sample. Bipolar Disord 2000; 2:281–293
26.
Jairam R, Srinath S, Girimaji SC, Seshadri SP: A prospective 4–5 year follow-up of juvenile onset bipolar disorder. Bipolar Disord 2004; 6:386–394
27.
Srinath S, Janardhan Reddy YC, Girimaji SR, Seshadri SP, Subbakrishna DK: A prospective study of bipolar disorder in children and adolescents from India. Acta Psychiatr Scand 1998; 98:437–442
28.
Strober M, Schmidt-Lackner S, Freeman R, Bower S, Lampert C, DeAntonio M: Recovery and relapse in adolescents with bipolar affective illness: a five-year naturalistic, prospective follow-up. J Am Acad Child Adolesc Psychiatry 1995; 34:724–731
29.
Post RM, Leverich GS, Kupka RW, Keck PE, McElroy SL, Altshuler LL, Frye MA, Luckenbaugh DA, Rowe M, Grunze H, Suppes T, Nolen WA: Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry 2010; 71:864–872
30.
Carlson GA, Bromet EJ, Driessens C, Mojtabai R, Schwartz JE: Age at onset, childhood psychopathology, and 2-year outcome in psychotic bipolar disorder. Am J Psychiatry 2002; 159:307–309
31.
Geoffroy PA, Etain B, Jamain S, Bellivier F, Leboyer M: [Early onset bipolar disorder: validation from admixture analyses and biomarkers]. Can J Psychiatry 2013; 58:240–248 (French)
32.
Perlis RH, Dennehy EB, Miklowitz DJ, Delbello MP, Ostacher M, Calabrese JR, Ametrano RM, Wisniewski SR, Bowden CL, Thase ME, Nierenberg AA, Sachs G: Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disord 2009; 11:391–400
33.
Suppes T, Leverich GS, Keck PE, Nolen WA, Denicoff KD, Altshuler LL, McElroy SL, Rush AJ, Kupka R, Frye MA, Bickel M, Post RM: The Stanley Foundation Bipolar Treatment Outcome Network, II: demographics and illness characteristics of the first 261 patients. J Affect Disord 2001; 67:45–59
34.
Haro JM, Reed C, Gonzalez-Pinto A, Novick D, Bertsch J, Vieta E, Board EAEMBLEM Advisory Board: 2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery. Eur Neuropsychopharmacol 2011; 21:287–293
35.
Oquendo MA, Waternaux C, Brodsky B, Parsons B, Haas GL, Malone KM, Mann JJ: Suicidal behavior in bipolar mood disorder: clinical characteristics of attempters and nonattempters. J Affect Disord 2000; 59:107–117
36.
Nolen WA, Luckenbaugh DA, Altshuler LL, Suppes T, McElroy SL, Frye MA, Kupka RW, Keck PE, Leverich GS, Post RM: Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network. Am J Psychiatry 2004; 161:1447–1454
37.
Romero S, Birmaher B, Axelson D, Goldstein T, Goldstein BI, Gill MK, Iosif AM, Strober MA, Hunt J, Esposito-Smythers C, Ryan ND, Leonard H, Keller M: Prevalence and correlates of physical and sexual abuse in children and adolescents with bipolar disorder. J Affect Disord 2009; 112:144–150
38.
Wilens TE, Biederman J, Adamson J, Monuteaux M, Henin A, Sgambati S, Santry A, Faraone SV: Association of bipolar and substance use disorders in parents of adolescents with bipolar disorder. Biol Psychiatry 2007; 62:129–134
39.
Goldstein BI, Strober M, Axelson D, Goldstein TR, Gill MK, Hower H, Dickstein D, Hunt J, Yen S, Kim E, Ha W, Liao F, Fan J, Iyengar S, Ryan ND, Keller MB, Birmaher B: Predictors of first-onset substance use disorders during the prospective course of bipolar spectrum disorders in adolescents. J Am Acad Child Adolesc Psychiatry 2013; 52:1026–1037
40.
Fiedorowicz JG, Endicott J, Solomon DA, Keller MB, Coryell WH: Course of illness following prospectively observed mania or hypomania in individuals presenting with unipolar depression. Bipolar Disord 2012; 14:664–671
41.
Grigoroiu-Serbănescu M, Christodorescu D, Jipescu I, Totoescu A, Marinescu E, Ardelean V: Psychopathology in children aged 10–17 of bipolar parents: psychopathology rate and correlates of the severity of the psychopathology. J Affect Disord 1989; 16:167–179

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 990 - 999
PubMed: 24874203

History

Received: 3 December 2013
Revision received: 20 February 2014
Accepted: 27 March 2014
Published online: 1 September 2014
Published in print: September 2014

Authors

Details

Boris Birmaher, M.D.
From the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh; the Department of Psychiatry, Nationwide Children’s Hospital and Ohio State College of Medicine, Columbus; the Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto Medical Center, Toronto; the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles; the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, R.I.; the Department of Psychiatry, Bradley Hospital, East Providence, R.I., and the Department of Psychiatry, Butler Hospital, Providence.
Mary Kay Gill, M.S.N.
From the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh; the Department of Psychiatry, Nationwide Children’s Hospital and Ohio State College of Medicine, Columbus; the Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto Medical Center, Toronto; the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles; the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, R.I.; the Department of Psychiatry, Bradley Hospital, East Providence, R.I., and the Department of Psychiatry, Butler Hospital, Providence.
David A. Axelson, M.D.
From the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh; the Department of Psychiatry, Nationwide Children’s Hospital and Ohio State College of Medicine, Columbus; the Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto Medical Center, Toronto; the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles; the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, R.I.; the Department of Psychiatry, Bradley Hospital, East Providence, R.I., and the Department of Psychiatry, Butler Hospital, Providence.
Benjamin I. Goldstein, M.D., Ph.D.
From the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh; the Department of Psychiatry, Nationwide Children’s Hospital and Ohio State College of Medicine, Columbus; the Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto Medical Center, Toronto; the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles; the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, R.I.; the Department of Psychiatry, Bradley Hospital, East Providence, R.I., and the Department of Psychiatry, Butler Hospital, Providence.
Tina R. Goldstein, Ph.D.
From the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh; the Department of Psychiatry, Nationwide Children’s Hospital and Ohio State College of Medicine, Columbus; the Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto Medical Center, Toronto; the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles; the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, R.I.; the Department of Psychiatry, Bradley Hospital, East Providence, R.I., and the Department of Psychiatry, Butler Hospital, Providence.
Haifeng Yu, M.S.
From the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh; the Department of Psychiatry, Nationwide Children’s Hospital and Ohio State College of Medicine, Columbus; the Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto Medical Center, Toronto; the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles; the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, R.I.; the Department of Psychiatry, Bradley Hospital, East Providence, R.I., and the Department of Psychiatry, Butler Hospital, Providence.
Fangzi Liao, M.S.
From the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh; the Department of Psychiatry, Nationwide Children’s Hospital and Ohio State College of Medicine, Columbus; the Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto Medical Center, Toronto; the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles; the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, R.I.; the Department of Psychiatry, Bradley Hospital, East Providence, R.I., and the Department of Psychiatry, Butler Hospital, Providence.
Satish Iyengar, Ph.D.
From the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh; the Department of Psychiatry, Nationwide Children’s Hospital and Ohio State College of Medicine, Columbus; the Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto Medical Center, Toronto; the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles; the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, R.I.; the Department of Psychiatry, Bradley Hospital, East Providence, R.I., and the Department of Psychiatry, Butler Hospital, Providence.
Rasim S. Diler, M.D.
From the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh; the Department of Psychiatry, Nationwide Children’s Hospital and Ohio State College of Medicine, Columbus; the Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto Medical Center, Toronto; the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles; the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, R.I.; the Department of Psychiatry, Bradley Hospital, East Providence, R.I., and the Department of Psychiatry, Butler Hospital, Providence.
Michael Strober, Ph.D.
From the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh; the Department of Psychiatry, Nationwide Children’s Hospital and Ohio State College of Medicine, Columbus; the Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto Medical Center, Toronto; the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles; the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, R.I.; the Department of Psychiatry, Bradley Hospital, East Providence, R.I., and the Department of Psychiatry, Butler Hospital, Providence.
Heather Hower, M.S.W.
From the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh; the Department of Psychiatry, Nationwide Children’s Hospital and Ohio State College of Medicine, Columbus; the Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto Medical Center, Toronto; the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles; the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, R.I.; the Department of Psychiatry, Bradley Hospital, East Providence, R.I., and the Department of Psychiatry, Butler Hospital, Providence.
Shirley Yen, Ph.D.
From the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh; the Department of Psychiatry, Nationwide Children’s Hospital and Ohio State College of Medicine, Columbus; the Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto Medical Center, Toronto; the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles; the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, R.I.; the Department of Psychiatry, Bradley Hospital, East Providence, R.I., and the Department of Psychiatry, Butler Hospital, Providence.
Jeffrey Hunt, M.D.
From the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh; the Department of Psychiatry, Nationwide Children’s Hospital and Ohio State College of Medicine, Columbus; the Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto Medical Center, Toronto; the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles; the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, R.I.; the Department of Psychiatry, Bradley Hospital, East Providence, R.I., and the Department of Psychiatry, Butler Hospital, Providence.
John A. Merranko, M.A.
From the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh; the Department of Psychiatry, Nationwide Children’s Hospital and Ohio State College of Medicine, Columbus; the Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto Medical Center, Toronto; the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles; the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, R.I.; the Department of Psychiatry, Bradley Hospital, East Providence, R.I., and the Department of Psychiatry, Butler Hospital, Providence.
Neal D. Ryan, M.D.
From the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh; the Department of Psychiatry, Nationwide Children’s Hospital and Ohio State College of Medicine, Columbus; the Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto Medical Center, Toronto; the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles; the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, R.I.; the Department of Psychiatry, Bradley Hospital, East Providence, R.I., and the Department of Psychiatry, Butler Hospital, Providence.
Martin B. Keller, M.D.
From the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh; the Department of Psychiatry, Nationwide Children’s Hospital and Ohio State College of Medicine, Columbus; the Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto Medical Center, Toronto; the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles; the Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, R.I.; the Department of Psychiatry, Bradley Hospital, East Providence, R.I., and the Department of Psychiatry, Butler Hospital, Providence.

Notes

Address correspondence to Dr. Birmaher ([email protected]).

Funding Information

Dr. Birmaher has received research support from NIMH and receives royalties from Random House, Lippincott Williams & Wilkins, and UpToDate. Dr. B. Goldstein is a consultant for Bristol-Myers Squibb, has received research support from Pfizer, and has received speaking honoraria from Purdue Pharma. Dr. Strober receives support from the Resnick Endowed Chair in Eating Disorders. Dr. Hunt receives honoraria from Wiley Publishers as a senior editor of the Brown University Child and Adolescent Psychopharmacology Update. Dr. Keller has received research support from NIMH and Pfizer, has received honoraria from Medtronic, Cenerex, and Sierra Neuropharmaceuticals, and is on the advisory board for Cenerex. The other authors report no financial relationships with commercial interests.
Supplementary Material
Supported by NIMH grant MH059929.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share